Cite
MLA Citation
Luis Paz‐Ares et al.. “RESILIENT part 1: a phase 2 dose‐exploration and dose‐expansion study of second‐line liposomal irinotecan in adults with small cell lung cancer.” Cancer, vol. 128, no. 9, 2022, pp. 1801–1811. http://access.bl.uk/ark:/81055/vdc_100153444449.0x00004c